PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced it awarded “inducement” options to two new employees under Rule 5635(c)(4) of the NASDAQ Marketplace Rules as an inducement for entering into employment with the Company. The options entitle the employees to purchase, outside of the Company’s stockholder approved equity incentive plans, an aggregate of up to 105,000 shares of the Company’s common stock at an exercise price per share of $7.98, the last reported closing price of the Company’s common stock on the date of grants. The options vest and become exercisable over a period of four years from the date of grant.
Help employers find you! Check out all the jobs and post your resume.